Apixaban is an anticoagulant medication used to treat and prevent blood clots and stroke in people with nonvalvular atrial fibrillation, marked by Bristol-Myers Squibb Co. as Eliquis with 40 DMF approved before 2021 Q3.

Prochem can provide pilot sample as white powder with above 99.90% purity.

Product Name: Apixaban

CAS Number: 503612-47-3

Indication: Anticoagulant

Specification: in-house (D₉₀ ≧ 89 mm)

Certificate: None

Non-infringement Description:

• US6413980B1 is original substance patent of Apixaban, and will expire on 2021.12.04.
• JP2002533465A is family patent of US6413980B1 in Japan, but do not approve by governmental authority.
• No related patent submitted in Taiwan.
• In this situation, no infringement concerns arise after 2021.12.04.